Sight Sciences (SGHT) Invested Capital (2020 - 2026)
Sight Sciences has reported Invested Capital over the past 6 years, most recently at $104.2 million for Q4 2025.
- For Q4 2025, Invested Capital fell 17.84% year-over-year to $104.2 million; the TTM value through Dec 2025 reached $104.2 million, down 17.84%, while the annual FY2025 figure was $104.2 million, 17.84% down from the prior year.
- Invested Capital for Q4 2025 was $104.2 million at Sight Sciences, up from $64.3 million in the prior quarter.
- Over five years, Invested Capital peaked at $264.8 million in Q4 2021 and troughed at -$246.0 million in Q3 2021.
- A 5-year average of $94.2 million and a median of $118.0 million in 2024 define the central range for Invested Capital.
- On a YoY basis, Invested Capital climbed as much as 565.36% in 2021 and fell as far as 207.62% in 2021.
- Year by year, Invested Capital stood at $264.8 million in 2021, then dropped by 26.96% to $193.4 million in 2022, then dropped by 20.29% to $154.1 million in 2023, then decreased by 17.69% to $126.9 million in 2024, then decreased by 17.84% to $104.2 million in 2025.
- Business Quant data shows Invested Capital for SGHT at $104.2 million in Q4 2025, $64.3 million in Q3 2025, and $70.0 million in Q2 2025.